Samsung Medical Center
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-05
- Last Posted Date
- 2024-04-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 154
- Registration Number
- NCT06350487
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-05
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT06350617
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Switching to E-cigarette After PCI
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-01
- Last Posted Date
- 2024-04-01
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 17442
- Registration Number
- NCT06338761
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved β₯50% LDL Reduction After PCI
- First Posted Date
- 2024-04-01
- Last Posted Date
- 2024-04-01
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 94189
- Registration Number
- NCT06338956
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients.
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2024-03-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT06330012
- Locations
- π°π·
Ji-Yeon Kim, Seoul, Korea, Republic of
Anesthesia and Non-small Cell Lung Cancer Recurrence
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2024-03-28
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 5384
- Registration Number
- NCT06330038
Brain Metastasis Development Mechanism in BCBM Patients
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2024-03-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT06330870
- Locations
- π°π·
Ji-Yeon Kim, Seoul, Korea, Republic of
Korea Hip Replacement Surgery Registry
Completed
- Conditions
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 124556
- Registration Number
- NCT06307145
Asymmetric High-flow Nasal Cannula (HFNC) vs Standard HFNC for Post Extubation High-risk Group
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-08
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT06301035
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 4657
- Registration Number
- NCT06281041
- Locations
- π°π·
Chonnam National University Medical School, Gwangju, Korea, Republic of
Β© Copyright 2024. All Rights Reserved by MedPath